Benefits of a clinical data warehouse with data mining tools to collect data for a radiotherapy trial

被引:47
作者
Roelofs, Erik [1 ]
Persoon, Lucas [1 ]
Nijsten, Sebastiaan [1 ]
Wiessler, Wolfgang [2 ]
Dekker, Andre [1 ]
Lambin, Philippe [1 ]
机构
[1] Maastricht Univ, Med Ctr, Dept Radiat Oncol, MAASTRO Clin, NL-6229 ET Maastricht, Netherlands
[2] Siemens Healthcare, Malvern, PA USA
关键词
Data warehouse; Clinical trials; Data quality; Efficiency; QUALITY-ASSURANCE; 2-YEAR SURVIVAL; ONCOLOGY TRIALS; CHALLENGES; PARTICIPATION; INFORMATICS; PREDICTION; PLATFORM; MODELS;
D O I
10.1016/j.radonc.2012.09.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Collecting trial data in a medical environment is at present mostly performed manually and therefore time-consuming, prone to errors and often incomplete with the complex data considered. Faster and more accurate methods are needed to improve the data quality and to shorten data collection times where information is often scattered over multiple data sources. The purpose of this study is to investigate the possible benefit of modern data warehouse technology in the radiation oncology field. Material and methods: In this study, a Computer Aided Theragnostics (CAT) data warehouse combined with automated tools for feature extraction was benchmarked against the regular manual data-collection processes. Two sets of clinical parameters were compiled for non-small cell lung cancer (NSCLC) and rectal cancer, using 27 patients per disease. Data collection times and inconsistencies were compared between the manual and the automated extraction method. Results: The average time per case to collect the NSCLC data manually was 10.4 +/- 2.1 min and 4.3 +/- 1.1 min when using the automated method (p < 0.001). For rectal cancer, these times were 13.5 +/- 4.1 and 6.8 +/- 2.4 min, respectively (p < 0.001). In 3.2% of the data collected for NSCLC and 5.3% for rectal cancer, there was a discrepancy between the manual and automated method. Conclusions: Aggregating multiple data sources in a data warehouse combined with tools for extraction of relevant parameters is beneficial for data collection times and offers the ability to improve data quality. The initial investments in digitizing the data are expected to be compensated due to the flexibility of the data analysis. Furthermore, successive investigations can easily select trial candidates and extract new parameters from the existing databases. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:174 / 179
页数:6
相关论文
共 38 条
[1]   Redesigning Radiotherapy Quality Assurance: Opportunities to Develop an Efficient, Evidence-Based System to Support Clinical Trials-Report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance [J].
Bekelman, Justin E. ;
Deye, James A. ;
Vikram, Bhadrasain ;
Bentzen, Soren M. ;
Bruner, Deborah ;
Curran, Walter J., Jr. ;
Dignam, James ;
Efstathiou, Jason A. ;
FitzGerald, T. J. ;
Hurkmans, Coen ;
Ibbott, Geoffrey S. ;
Lee, J. Jack ;
Merchant, Thomas E. ;
Michalski, Jeff ;
Palta, Jatinder R. ;
Simon, Richard ;
Ten Haken, Randal K. ;
Timmerman, Robert ;
Tunis, Sean ;
Coleman, C. Norman ;
Purdy, James .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (03) :782-790
[2]   An "in silico" clinical trial comparing free breathing, slow and respiration correlated computed tomography in lung cancer patients [J].
Bosmans, Geert ;
Buijsen, Jeroen ;
Dekker, Andre ;
Velders, Marije ;
Boersma, Liesbeth ;
De Ruysscher, Dirk ;
Minken, Andre ;
Lambin, Philippe .
RADIOTHERAPY AND ONCOLOGY, 2006, 81 (01) :73-80
[3]  
Branson A, 2008, STUD HEALTH TECHNOL, V138, P13
[4]   IMPROVING NORMAL TISSUE COMPLICATION PROBABILITY MODELS: THE NEED TO ADOPT A "DATA-POOLING" CULTURE [J].
Deasy, Joseph O. ;
Bentzen, Soren M. ;
Jackson, Andrew ;
Ten Haken, Randall K. ;
Yorke, Ellen D. ;
Constine, Louis S. ;
Sharma, Ashish ;
Marks, Lawrence B. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03) :S151-S154
[5]   Tumor volume combined with number of positive lymph node stations is a more important prognostic factor than TNM stage for survival of non-small-cell lung cancer patients treated with (chemo)radiotherapy [J].
Dehing-Oberije, Cary ;
De Ruysscher, Dirk ;
van der Weide, Hiska ;
Hochstenbag, Monique ;
Bootsma, Gerben ;
Geraedts, Wiel ;
Pitz, Cordula ;
Simons, Jean ;
Teule, Jaap ;
Rahmy, Ali ;
Thimister, Paul ;
Steck, Harald ;
Lambin, Philippe .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (04) :1039-1044
[6]   The importance of patient characteristics for the prediction of radiation-induced lung toxicity [J].
Dehing-Oberije, Cary ;
De Ruysscher, Dirk ;
van Baardwijk, Angela ;
Yu, Shipeng ;
Rao, Bharat ;
Lambin, Philippe .
RADIOTHERAPY AND ONCOLOGY, 2009, 91 (03) :421-426
[7]   DEVELOPMENT AND EXTERNAL VALIDATION OF PROGNOSTIC MODEL FOR 2-YEAR SURVIVAL OF NON-SMALL-CELL LUNG CANCER PATIENTS TREATED WITH CHEMORADIOTHERAPY [J].
Dehing-Oberije, Cary ;
Yu, Shipeng ;
De Ruysscher, Dirk ;
Meersschout, Sabine ;
Van Beek, Karen ;
Lievens, Yolande ;
Van Meerbeeck, Jan ;
De Neve, Wilfried ;
Rao, Bharat ;
van der Weide, Hiska ;
Lambin, Philippe .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (02) :355-362
[8]   AD-HOC DATA SHARING INFRASTRUCTURE FOR RADIOTHERAPY RESEARCH COLLABORATION: A TOOL FOR MULTICENTRIC CLINICAL RESEARCH [J].
Dekker, A. ;
Roelofs, E. ;
Meldolesi, E. ;
Valentini, V. ;
Lambin, P. .
RADIOTHERAPY AND ONCOLOGY, 2011, 99 :S155-S156
[9]  
Dekker A, RADIOTHER ONCO UNPUB
[10]  
El Fadly AbdenNaji, 2011, J Biomed Inform, V44 Suppl 1, pS94, DOI 10.1016/j.jbi.2011.07.007